Egypt focuses on pharmaceutical autonomy: a national strategy for the future
- Home
- Latest News
- April 30, 2025
On March 20, 2025, the Egyptian Prime Minister, Mostafa Madbouli, reiterated the State’s will to strengthen the local production of medicines. This strategy is part of a global plan aiming to ensure the coverage of national needs while boosting exports to foreign markets.
During a meeting with the Minister of Health, Khaled Abdel Ghaffar, an ambitious program was presented to localize the manufacturing of non-active pharmaceutical substances. Of the 280 targeted ingredients, a first phase plans for the production of 30 key components. These represent more than 60% of the current import value in this category, which would ultimately allow a significant reduction in foreign currency spending and strengthen the country’s industrial sovereignty.
Currently, national production covers 93% of medicine needs. The government aims to reach a coverage rate of 95% by 2030. In parallel, exports of pharmaceutical and medical products amounted to 1.5 billion dollars for the 2024/2025 fiscal year. The objective is to double this figure by 2030.
Beyond medicines, Egypt is working to develop the production of vaccines, medical equipment, and imaging devices, in partnership with international companies. These projects also aim to make the country a regional hub for export to African markets.
This new industrial strategy reflects a clear will: to build a strong national pharmaceutical sector, capable of meeting the population’s needs, resisting global crises, and contributing to the country’s economic growth.
Contact us and meet TTE Gulf experts to get your consultation on what is the best approach for your investment in Egypt.
United Arab Emirates
Saudi Arabia
Egypt
FRANCE© 2025 TTE Gulf Management Consultancy. All rights reserved
FRANCE© 2024 TTE Gulf Management Consultancy. All rights reserved
